4//SEC Filing
Brown Michael J 4
Accession 0001437749-25-029925
CIK 0001645469other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 3:53 PM ET
Size
9.9 KB
Accession
0001437749-25-029925
Insider Transaction Report
Form 4
Robinson Chandler
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-09-24$63.61/sh−550,229$34,999,957→ 272,026 total
BROWN MICHAEL J
Other
Transactions
- Sale
Common Stock
2025-09-24$63.61/sh−550,229$34,999,957→ 272,026 total
O'Halloran Thomas V.
Other
Transactions
- Sale
Common Stock
2025-09-24$63.61/sh−550,229$34,999,957→ 272,026 total
Mazar Andrew Paul
Other
Transactions
- Sale
Common Stock
2025-09-24$63.61/sh−550,229$34,999,957→ 272,026 total
Tactic Pharma LLC
10% Owner
Transactions
- Sale
Common Stock
2025-09-24$63.61/sh−550,229$34,999,957→ 272,026 total
Footnotes (1)
- [F1]This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. The Reporting Persons are no longer subject to Section 16, except for Chandler D. Robinson, who serves as Chief Executive Officer of Monopar Therapeutics Inc.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
Related Parties
1- filerCIK 0001035909
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 3:53 PM ET
- Size
- 9.9 KB